We are live on
!
Find out more
ACM
Argyle Capital Management Portfolio holdings
AUM
$347M
1-Year Est. Return
44.33%
This Fund
S&P 500
This Quarter
Est. Return
-2.8%
1 Year Est. Return
+44.33%
3 Year Est. Return
+95.77%
5 Year Est. Return
+124.66%
10 Year Est. Return
+325.03%
AUM
$254M
AUM Growth
+$2.65M
(+1.1%)
Cap. Flow
+$13.1M
Cap. Flow
% of AUM
5.18%
Top 10 Holdings %
Top 10 Hldgs %
26.44%
Holding
129
New
5
Increased
82
Reduced
14
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Global Payments
GPN
|
+$934K |
| 2 |
NXP Semiconductors
NXPI
|
+$920K |
| 3 |
Texas Instruments
TXN
|
+$674K |
| 4 |
Dell
DELL
|
+$617K |
| 5 |
Chubb
CB
|
+$583K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$285K |
| 2 |
Viatris
VTRS
|
+$119K |
| 3 |
OraSure Technologies
OSUR
|
+$42.8K |
| 4 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$28.3K |
| 5 |
Devon Energy
DVN
|
+$18.8K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.34% |
| 2 | Healthcare | 19.62% |
| 3 | Financials | 13.83% |
| 4 | Industrials | 13.25% |
| 5 | Energy | 7.96% |
Similar funds
GCP
AWA
WC
LAM
FFA
VW
1CP
NC
Argyle Capital Management's Q4 2024 Portfolio in Review
As of Q4 2024, Argyle Capital Management held 129 positions worth $254M, up 1.1% from $251M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Argyle Capital Management deployed $13.1M of net new capital in Q4 2024, opening 5 new positions and adding to 82 existing holdings. Its largest new stake was Global Payments: 8,537 shares worth $957K.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $285K trimmed.
- Argyle Capital Management's largest Q4 2024 buy was Global Payments: 8,537 shares worth $957K.
- Argyle Capital Management added most to Dell in Q4 2024, an estimated $617K increase.
- Argyle Capital Management's biggest Q4 2024 reduction was CVS Health, cutting an estimated $285K.
- Argyle Capital Management fully exited Viatris in Q4 2024, selling an estimated $119K.
- Argyle Capital Management's ten largest holdings make up 26% of its $254M portfolio in Q4 2024.
- Argyle Capital Management opened 5 new positions and closed 2 in Q4 2024.
- Argyle Capital Management's portfolio value rose 1.1% quarter-over-quarter to $254M.
Based on Argyle Capital Management's 13F filing for Q4 2024, filed 5 Feb 2025.